The Renal Failure Challenge: A Hidden Opportunity

Early detection of renal failure is critical for effective patient management and therapeutic interventions. Traditional methods often rely on invasive tests and have limitations in identifying at-risk populations. This presents a significant challenge for pharmaceutical companies seeking to develop and market treatments for kidney disease.

The Cost of Missed Renal Failure Opportunities

Delayed diagnosis of renal failure can lead to:

• Increased risk of cardiovascular disease
• Accelerated progression to end-stage renal disease
• Higher healthcare costs
• Reduced quality of life for patients

These consequences can significantly impact a pharmaceutical company’s bottom line and reputation.

Kribado: Your Solution to the Renal Failure Challenge

Kribado is a cutting-edge patient screening device designed to enhance renal failure risk assessment. By providing rapid and accurate risk scores, Kribado empowers healthcare providers to:

• Identify patients at high risk of renal failure
• Optimize patient management
• Improve clinical trial recruitment
• Drive data-driven decision-making

How Kribado Works

Kribado’s user-friendly interface and advanced algorithms streamline the patient screening process. With a simple touch-screen and embedded printer, healthcare professionals can:

• Collect patient data efficiently
• Generate instant renal failure risk scores
• Stratify patients based on risk levels
• Stratify patients based on risk levels